Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

• Status: Not yet recruiting
• Trial end date: 2024-12-01

Summary

The purpose of this study is to compare mepolizumab-based regimen to conventional therapeutic strategy for remission induction in patients with Eosinophilic Granulomatosis with Polyangiitis.

• Phase: Phase 3

Details

• Lead Sponsor: Assistance Publique - Hôpitaux de Paris
• Collaborators: French Vasculitis Study Group; URC-CIC Paris Descartes Necker Cochin
• Treatments: Azathioprine; Cyclophosphamide